Bridgewater Associates LP grew its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 4.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 294,827 shares of the company’s stock after acquiring an additional 13,225 shares during the period. Bridgewater Associates LP owned about 0.13% of Bath & Body Works worth $9,411,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. First Community Trust NA purchased a new stake in Bath & Body Works during the second quarter worth $30,000. Livforsakringsbolaget Skandia Omsesidigt grew its stake in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Meeder Asset Management Inc. grew its stake in Bath & Body Works by 480.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,436 shares during the last quarter. GAMMA Investing LLC increased its holdings in Bath & Body Works by 65.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock valued at $72,000 after acquiring an additional 730 shares in the last quarter. Finally, Abich Financial Wealth Management LLC acquired a new position in Bath & Body Works during the third quarter worth about $103,000. 95.14% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have recently weighed in on BBWI shares. TD Cowen raised their price objective on shares of Bath & Body Works from $40.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research note on Monday. UBS Group dropped their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Finally, Evercore ISI reduced their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.88.
Bath & Body Works Trading Up 1.9 %
Shares of Bath & Body Works stock opened at $35.90 on Friday. The business’s fifty day moving average price is $30.93 and its 200 day moving average price is $35.65. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The stock has a market capitalization of $7.87 billion, a P/E ratio of 8.76, a PEG ratio of 1.14 and a beta of 1.79.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current year.
Bath & Body Works Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.23%. Bath & Body Works’s dividend payout ratio (DPR) is 19.51%.
Insiders Place Their Bets
In related news, CEO Gina Boswell bought 6,000 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is owned by insiders.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Best Stocks Under $10.00
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Dividend King?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.